Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and accessing a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of opportunities amidst rising vacancy rates.

Co-GP / Platform:A family office could deploy into the San Francisco Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and access a pipeline of projects.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and gaining access to a pipeline of projects.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor or operator at the GP level, focusing on life sciences developments with strong demand.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of life sciences projects.

Co-GP / Platform:A family office could deploy into the San Francisco Bay Area life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the San Francisco life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from a repeatable pipeline of leasing opportunities.

Co-GP / Platform:A family office could deploy into this market by partnering with established life sciences operators at the GP level to share in the promote and benefit from the sector's growth.

Co-GP / Platform:A family office could deploy into the San Francisco Bay Area life sciences market by backing a sponsor or operator at the GP level, capitalizing on the growing demand for larger spaces and the influx of new inventory.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, particularly in light of the significant capital raised by companies like ArsenalBio and Caresyntax.

Co-GP / Platform:A family office could deploy into the San Francisco life science market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from a robust pipeline of new developments.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator in the life sciences sector, focusing on co-GP or JV equity to share in the promote and benefit from a repeatable pipeline of developments.

Co-GP / Platform:A family office could deploy into the San Francisco Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from a repeatable deal flow.

Co-GP / Platform:A family office could deploy into the San Francisco Bay Area life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from a repeatable pipeline of developments.

Co-GP / Platform:A family office could deploy into the San Francisco Life Science market by backing a sponsor with a proven track record in lab space development to share in the promote and future value.